Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human...
Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells
About this item
Full title
Author / Creator
ter Ellen, Bram M. , Dinesh Kumar, Nilima , Bouma, Ellen M. , Troost, Berit , van de Pol, Denise P.I. , van der Ende-Metselaar, Heidi H. , Apperloo, Leonie , van Gosliga, Djoke , van den Berge, Maarten , Nawijn, Martijn C. , van der Voort, Peter H.J. , Moser, Jill , Rodenhuis-Zybert, Izabela A. and Smit, Jolanda M.
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has an enormous impact on human health and economy. In search for therapeutic options, researchers have proposed resveratrol, a food supplement with known antiviral, anti-inflammatory, and antioxidant properties as an advantageous antiviral t...
Alternative Titles
Full title
Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_16c9bf2d5c77475aa3281a9cc2e0e074
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_16c9bf2d5c77475aa3281a9cc2e0e074
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v13071335
